Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

NCT05368103 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen